Performance of study partner reports in a non-demented at-risk sample

Abstract

INTRODUCTION

The Clinical Dementia Rating (CDR) Scale is a gold standard for staging impairment in Alzheimer's disease and other dementias (ADRD). The Quick Dementia Rating System (QDRS) offers similar results in 3 to 5 minutes without a trained clinician. This study aimed to (1) investigate concordance between comparably derived QDRS and CDR global scores, (2) examine item-level QDRS/CDR agreement, and (3) compare sample characteristics and cognitive performance across QDRS/CDR global concordant/discordant groups.

METHODS

The study included 351 QDRS/CDR pairs from 297 participants in the Wisconsin Registry for Alzheimer's Prevention (WRAP). Analyses included descriptive indices of QDRS/CDR agreement, lasso logistic regression, tetrachoric correlations, and linear mixed models.

RESULTS

The QDRS global/CDR global concordance rate is 70.66%. Memory item discrepancies were primarily responsible for QDRS/CDR global rating discordance. Average cognitive scores were highest in concordant-normal QDRS/CDR and lowest in concordant-abnormal QDRS/CDR.

DISCUSSION

The QDRS effectively screened for impairment in this sample. Future analyses will investigate QDRS relations to ADRD biomarkers.

Highlights

• The Quick Dementia Rating System (QDRS) effectively screened for impairment in Alzheimer's disease and other dementias (ADRD) in a non-demented sample.
• Concordance rate between QDRS_CDR global and Clinical Dementia Rating (CDR) Scale global scores is 70.66%.
• Memory item discrepancies primarily cause QDRS/CDR global score discordance.
• Cognitive scores are associated with QDRS/CDR concordances/discordances.
• Future analyses will explore QDRS relations to ADRD biomarkers.